Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November Life Science Investing
Foamix Announces Additional Positive Topline Results from Third Phase 3 Trial Evaluating FMX101 Life Science Investing
Dermira’s QBREXZA (glycopyrronium) Cloth Is Now Available in Pharmacies Nationwide Pharmaceutical Investing
AVROBIO Receives No Objection to Clinical Trial Application from Health Canada for AVR-RD-02 Gene Therapy for Gaucher Disease Biotech Investing
AVROBIO Announces Updated Clinical Data for AVR-RD-01 Gene Therapy in Fabry Disease Biotech Investing
Microbot Medical Announces Commencement of Pivotal Study for its Self-Cleaning Shunt Medical Device Investing
Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy Pharmaceutical Investing
Therma Bright Provides Corporate Update on Pain Relief Device Incorporating Medicinal Cannabis, Further Testing of TherOZap(TM) Technology Biotech Investing
Harvest One Expands National Retail Presence with Manitoba Supply Agreement and Becomes a Registered Supplier in Saskatchewan Cannabis Investing News
Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply Cannabis Investing News
Big News Roundup: Relay Medical To Commence Trading in United States as RYMDF; BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study; Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain Biotech Investing
